1,058 results on '"Reindl, Markus"'
Search Results
102. Complement Activation Is a Prominent Feature ofMOGAD
103. Multiple Amino Acid Sequence Alignment of the Major Outer Surface Proteins OspA and OspB of Various Borrelia Burgdorferi Strains
104. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients
105. Age-Dependent Seroprevalence of JCV Antibody in Children
106. Natalizumab treatment reduces endothelial activity in MS patients
107. Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
108. Features of intrathecal immunoglobulins in patients with multiple sclerosis
109. Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses
110. sj-pdf-1-mso-10.1177_20552173211022767 - Supplemental material for Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients
111. Additional file 1 of German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis
112. Additional file 1 of Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
113. Additional file 3 of German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis
114. Additional file 2 of German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis
115. Endovascular Cooling and Endothelial Activation in Hemorrhagic Stroke Patients
116. Functional Recovery in Autoimmune Encephalitis: A Prospective Observational Study
117. NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders
118. MOG-Abs in CSF only: pathological findings support the diagnostic role (4181)
119. Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients
120. AQP4 autoantibodies in patients with idiopathic normal pressure hydrocephalus
121. Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients
122. Effects of Erythropoietin on Frataxin Levels and Mitochondrial Function in Friedreich Ataxia – a Dose–Response Trial
123. Pathogenic T cell responses against aquaporin 4
124. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis
125. Intrathecal anti-αB-crystallin IgG antibody responses: Potential inflammatory markers in Guillain-Barré syndrome
126. Role of Autoantibodies in Acquired Inflammatory Demyelinating Diseases of the Central Nervous System in Children
127. 6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
128. Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF
129. Additional file 1 of Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes
130. Additional file 7 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
131. Additional file 1 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
132. Additional file 4 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
133. Additional file 5 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
134. Additional file 8 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
135. Additional file 6 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
136. Additional file 4 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
137. Additional file 2 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
138. Additional file 1 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
139. Additional file 3 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
140. Additional file 3 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
141. Additional file 5 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
142. Additional file 7 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
143. Multiple sclerosis: Disease biomarkers as indicated by pathophysiology
144. Animal models of multiple system atrophy
145. Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up
146. MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
147. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
148. Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy)
149. GDNF and TGF-β1 promote cell survival in serum-free cultures of primary rat microglia
150. The spectrum of MOG autoantibody-associated demyelinating diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.